Specify a stock or a cryptocurrency in the search bar to get a summary
Sprint Bioscience AB
SPRINTSprint Bioscience AB (publ), a pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden. It develops VPS34, a drug candidate for the treatment of various types of cancer by using immunotherapies; and PETRA01, a drug candidate for the treatment of cancer. The company also focuses on research of products for the treatment of tumor metabolism, nash, and diabetes. Sprint Bioscience AB (publ) was incorporated in 2009 and is based in Huddinge, Sweden. Address: Novum, Huddinge, Sweden, 141 57
Analytics
WallStreet Target Price
29.48 SEKP/E ratio
6.2Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures SPRINT
Dividend Analytics SPRINT
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History SPRINT
Stock Valuation SPRINT
Financials SPRINT
Results | 2019 | Dynamics |